Literature DB >> 3950049

Influence of laboratory sensitivity reporting on antibiotic prescribing preferences of general practitioners in the Leeds area.

P Langdale, M R Millar.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 3950049      PMCID: PMC499692          DOI: 10.1136/jcp.39.2.233

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  5 in total

1.  [Detection of bacterial inhibitors in urine and their preliminary identification].

Authors:  R Fischer; W Sämisch
Journal:  Z Gesamte Hyg       Date:  1977

2.  Co-trimoxazole toxicity.

Authors:  R W Lacey; P M Hawkey; S K Devaraj; M R Millar; T J Inglis; P G Godwin
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-17

3.  Simple microbiological method for the identification of antimicrobial agents prescribed in general practice.

Authors:  M R Millar; P Langdale
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

4.  Inhibitory substances in urine: an addition to the routine screen.

Authors:  W Pelling
Journal:  Med Lab Sci       Date:  1982-10

5.  Costs of unnecessary tests: nonsense urines.

Authors:  J G Cruickshank; A H Gawler; R J Hart
Journal:  Br Med J       Date:  1980-06-07
  5 in total
  2 in total

1.  Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: a case-vignette randomised study.

Authors:  C Coupat; C Pradier; N Degand; P Hofliger; C Pulcini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-08       Impact factor: 3.267

2.  Staphylococcus aureus - selective reporting of antibiogram results and its impact on antibiotic use: Interventional study with a reference group on the effect of switching from non-selective to selective antibiotic reporting.

Authors:  Franka Lestin-Bernstein; Ramona Harberg; Ingo Schumacher; Lutz Briedigkeit; Oliver Heese; Kristina Biedermann
Journal:  Antimicrob Resist Infect Control       Date:  2021-11-06       Impact factor: 4.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.